Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore complex-interacting protein family member B7 pseudogene (NPIPB7 pseudogene; ENSG00000274730) is classified as a pseudogene, which means it is a non-functional segment of DNA that resembles a gene but typically does not encode an active protein product[2][3][4]. It belongs to a family related to nuclear pore complex-interacting proteins, which are part of the cellular machinery that regulates transport between the nucleus and cytoplasm, but as a pseudogene, NPIPB7 does not have a recognized function, is not considered a direct molecular target, and is not associated with therapeutic drugs or disease relevance[2][3][9]. The entry is considered incorrect if the intention is to identify an active or functional drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex-interacting protein family member B7 pseudogene (NPIPB7 pseudogene).